PhD Microbiology and Molecular biology, UNSW, Sydney, Australia 2021
Bachelors of microbiology, Hazara University Mansehra, Pakistan 2010
M.Phil Microbiology, Hazara University Mansehra, Pakistan 2012
Bachelors of Education (B.ed), Sarhad University, Pakistan 2015
Mahjabeen Khan completed her PhD in Microbiology and Molecular Biology from UNSW. Due to best performance in research during her PhD by generating impactful output in the form of research publications and was awarded the Brian and Kirby award for research excellence. She pursued her PhD with the prestigious scholarship offered by UNSW in 2016 in School of Optometry and Vision Science (SOVS) and she received scholarship and started her PhD in 2017 where she explored the bacteria P. aeruginosa in causing eye infections in human. The key findings for this bacterium included the clonal relationship between recent and historical isolates where recent isolates acquired many resistance genes which were novel for the eye infections. The outcome of these findings resulted in number of publications in the Q1 and Q2 journals.
Currently she is working as a visiting Research Fellow at SOVS UNSW by engaging in the industry collaborative projects and completed successfully two projects based on the development of novel disinfection systems. Findings of the project based on the UV- based disinfection had been published in the journal Hygiene. Dr Khan is also running number of other projects including genome sequencing of ocular bacteria, development of bacteriophages against ocular bacteria and investigation of ocular microbiome changes due to mask wear.
Brian Kirby Award for best thesis 2021
Fellowship for American Society for Microbiology, 2021
Mahjabeen research activities involve the analysis of bacterial genomes to find out the reasons of antimicrobial resistance including antibiotics as well as disinfectants. The research also focuses on the infection control and measures in the hospital environment to improve the disinfection of intensive care units and it involves the development of novel disinfectants.